Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
New Biotechnology|September 28, 2015
Development of a magnetic bead-based method for the collection of circulating extracellular vesiclesChun-Liang Shih, Kowit-Yu Chong, Shih-Che Hsu, et al.
Cancer Management and Research|December 10, 2019
Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian MelanomaJohn Wen-Cheng Chang, Yen-Lin Huang, Yao-Yu Chang, et al.
Cancer Genomics & Proteomics|December 29, 2019
Transcriptomic Analysis in Liquid Biopsy Identifies Circulating PCTAIRE-1 mRNA as a Biomarker in NSCLCJohn Wen-Cheng Chang, Chun-Liang Shih, Chih-Liang Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 9, 2024
Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancerJin-Yuan Shih, Yung-Hung Luo, Gee-Chen Chang, et al.
Thoracic Cancer|May 28, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patientsJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Thoracic Cancer|November 25, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from TaiwanJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Therapeutic Advances in Respiratory Disease|October 28, 2022
Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutationsPing-Chih Hsu, John Wen-Cheng Chang, Ching-Fu Chang, et al.
Cancers|February 25, 2022
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKIJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Thoracic Cancer|December 16, 2022
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancerJohn Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, et al.
Aging|January 9, 2024
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective studyLing-Jen Hung, Ping-Chih Hsu, Cheng-Ta Yang, et al.
Pageof 19